ORAMED PHARMACEUTICALS INC (ORMP)
US68403P2039 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-8-31) | 2020 (2020-8-31) | 2019 (2019-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 5.09M | -37.76M | -22.99M | -11.51M | -14.36M | |||
| Depreciation Amortization | 196.00K | 60.00K | 80.00K | 10.00K | 10.00K | |||
| Change In Working Capital | -2.70M | -940.00K | -1.32M | -3.16M | 290.00K | |||
| Interest Paid | 574.00K | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 0.00 | 100.00K | 100.00K | 0.00 | 300.00K | |||
| Other non cash items | -12.88M | 10.73M | 3.05M | 2.22M | 1.12M | |||
| OPERATING CASH FLOW | -10.29M | -27.92M | -21.18M | -12.44M | -12.94M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -254.00K | -500.00K | -380.00K | -80.00K | -20.00K | |||
| Other Investing Activity | -72.78M | 30.71M | -23.39M | 4.71M | 11.27M | |||
| INVESTING CASH FLOW | -73.04M | 30.21M | -23.76M | 4.63M | 11.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 49.55M | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 2.43M | 11.56M | 101.39M | 23.79M | 0.00 | |||
| Other Financing Activity | N/A | -780.00K | 1.50M | N/A | N/A | |||
| FINANCING CASH FLOW | 51.98M | 10.78M | 102.89M | 23.79M | 0.00 | |||
| Exchange Rate Effect | -54.00K | -60.00K | 0.00 | -10.00K | 10.00K | |||
| CHANGE IN CASH | -31.41M | 13.01M | 57.95M | 15.97M | -1.67M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.29M | -27.92M | -21.18M | -12.44M | -12.94M | |||
| Capital Expenditure | -254.00K | -500.00K | -380.00K | -80.00K | -20.00K | |||
| FREE CASH FLOW | -10.55M | -28.42M | -21.56M | -12.52M | -12.96M | |||
All data in USD